# Vertex Acquires Crinetics Pharmaceuticals in ~$10 Billion Deal

> ma · REPORTED · 2026-07-07

Vertex Pharmaceuticals announced a takeover bid for Crinetics Pharmaceuticals, sending Crinetics' shares up nearly 99% in pre-market trading, in a move signaling Vertex's strategic foray into endocrine disease drugs. The acquisition expands Vertex's portfolio well beyond its established cystic fibrosis franchise.

About Vertex Pharmaceuticals: Crinetics Pharmaceuticals is a clinical-stage biopharmaceutical company developing small molecule therapeutics for endocrine diseases and endocrine-related tumors, including acromegaly and Cushing's disease.

- Company: Vertex Pharmaceuticals
- Sector: biotech
- Primary source: https://www.thepharmaletter.com/mergers-acquisitions

---
Source: MedFuel Intel news monitor. Verification tier: REPORTED. Informational only, not investment advice. Corrections: media@medfuelinc.com.